论文部分内容阅读
To accelerate the drug release profile,dual or multi stimuli-responsive nanocarriers are promising candidates for the active therapeutic uptake in cancer cells[1].Phospholipid or phospholipid mimic polymer bioconjugates provide good biocompatibility,micellar stability and reduced burst drug release[2].